Electrical stimulation vs drug therapy
- Electrical stimulation with non‐implanted electrodes for overactive bladder in adults 2016 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 336 participantsLow
Electrical stimulation may leads to lower adverse effects ‐ ES versus oxybutynin compared with drug therapy (low certainty).
Electrical stimulation probably leads to lower adverse effects ‐ ES versus tolterodine compared with drug therapy (moderate certainty).
It is very uncertain whether electrical stimulation changes adverse effects ‐ ES versus solifenacin succinate compared with drug therapy (very low certainty).
Electrical stimulation probably leads to higher participants cured or improved compared with placebo or sham treatment (moderate certainty).
Electrical stimulation showed no clear difference in participants with improvement in urgency urinary incontinence compared with placebo or sham treatment (low certainty).
Electrical stimulation showed no clear difference in adverse effects compared with placebo or sham treatment (low certainty).
Electrical stimulation probably leads to higher participants cured or improved compared with pelvic floor muscle training (PFMT) (moderate certainty).
It is very uncertain whether electrical stimulation (ES) once a week changes participants cured or improved ( compared with ES three times a week (very low certainty).
It is very uncertain whether electrical stimulation (ES) once a week changes participants with improvement in urgency urinary incontinence ( compared with ES three times a week (very low certainty).
It is very uncertain whether electrical stimulation plus drug therapy changes adverse effects compared with drug therapy alone (very low certainty).
Electrical stimulation probably leads to higher cure: number of women with self‐reported continence compared with no active treatment (moderate certainty).